Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yu Li

6PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Nov 20, 2024

Association Between Antibiotic and Outcomes of Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: A Multicenter Retrospective Study of 132 Patients.

Fang Deng, Hong Ye, Ping Zhang

|Nov 17, 2024

Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non-small Cell Lung Cancer Patients: A Retrospective Cohort Study.

Fang Deng, Xiuwei Du, Ping Zhang

|Feb 25, 2024

The inhibitory effect of apatinib on different small cell lung cancer cells and in lung cancer-bearing mice and patients.

Mingtao Liu, Hui Li, Ranran Guo

|Dec 02, 2021

Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs.

Peng Jiang, Yan Zhang, Jiadong Cui

|Nov 06, 2021

Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.

Pengfei Pan, Fengjuan Wu, Zhiyun Xu

|Feb 06, 2021

Efficacy and tolerability of bevacizumab in patients with severe Covid-19.

Jiaojiao Pang, Feng Xu, Gianmarco Aondio

Pageof 1

Frequent Collaborators

2 joint publications

Zhongfei Yang

1 joint publications

Jiaojiao Pang

1 joint publications

Feng Xu

1 joint publications

Alberto Fumagalli

1 joint publications

Ming Lu

1 joint publications

Yuan Bian

1 joint publications

Giovanni Damiani

1 joint publications

Yuan Zhang

1 joint publications

Dexin Yu

1 joint publications

Jun Chen

Frequent Collaborators

2 joint publications

Zhongfei Yang

1 joint publications

Jiaojiao Pang

1 joint publications

Feng Xu

1 joint publications

Alberto Fumagalli

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on : Jan 19, 2019

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos